Skip to main content
Yixintang Pharmaceutical Group Co., Ltd. logo

Yixintang Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 002727 ISIN · CNE100001WJ8 LEI · 300300NE1YJT00E9JD69 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 2,825 across all filing types
Latest filing 2025-12-18 Director's Dealing
Country CN China
Listing Shenzhen Stock Exchange 002727

About Yixintang Pharmaceutical Group Co., Ltd.

https://www.hx8886.com

Yixintang Pharmaceutical Group Co., Ltd. operates an extensive network of retail pharmacies providing a broad spectrum of healthcare products and services. The company specializes in the distribution of Western pharmaceuticals, traditional Chinese medicine (TCM), medical equipment, and health supplements. Its operational model integrates physical storefronts with digital platforms to facilitate online-to-offline (O2O) services, including prescription fulfillment and health consultations. Key offerings include chronic disease management, professional pharmaceutical advice, and a diverse inventory of over-the-counter (OTC) medications. The company focuses on community-based health accessibility, utilizing a robust supply chain to ensure product quality and availability across its service regions.

Recent filings

Filing Released Lang Actions
关于实际控制人内部转让公司股份实施完成的公告
Director's Dealing Classification · 95% confidence The document is an announcement regarding the completion of an internal transfer of company shares among related parties (the controlling shareholder transferring shares to his daughters). It details the share transfer method, share quantities, prices, and confirms no change in control or governance structure. The document is a formal disclosure of a shareholding transaction by a director and controlling shareholder, including signing of agreements and compliance with regulatory requirements. It does not contain financial statements, earnings data, or management discussion. It is not a report or presentation but a regulatory announcement about insider share transactions. Therefore, it fits the category of Director's Dealing (DIRS). The document length is short and focused on share transactions by directors, confirming this classification with high confidence.
2025-12-18 Chinese
北京市竞天公诚律师事务所关于一心堂药业集团股份有限公司2025年度第四次临时股东会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, attendance, voting procedures, and results of a company's 2025 fourth extraordinary general meeting of shareholders. It details the legal compliance of the meeting process, the qualifications of attendees, and the voting outcomes on various proposals. The document is not a financial report, earnings release, or management discussion, but rather a formal legal opinion on the shareholder meeting and its resolutions. This type of document is best classified as a Declaration of Voting Results & Voting Rights Announcements (DVA), as it provides official results and legal validation of shareholder votes at a general meeting.
2025-12-10 Chinese
2025年度第四次临时股东会暨中小投资者表决结果公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed announcement of the voting results from a shareholders' meeting, specifically the 2025 fourth extraordinary general meeting (EGM) of Yixintang Pharmaceutical Group Co., Ltd. It includes detailed voting outcomes on multiple proposals, attendance information, legal opinions on the meeting's validity, and references to the meeting resolutions and legal opinion letters. There is no financial data or management discussion of results, nor is it a report or presentation. The content matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length and detail confirm it is the voting results announcement itself, not just a brief notice or report publication announcement.
2025-12-10 Chinese
关于使用部分暂时闲置自有资金进行现金管理到期收回的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company about the use of temporarily idle funds for cash management, detailing the maturity and recovery of such funds from various bank products. It includes tables of financial products, amounts, yields, and contract dates. The document is a formal public announcement regarding the company's cash management activities and the recovery of funds, not a full financial report or audit. It does not contain comprehensive financial statements or detailed management analysis. It is not a report publication announcement since it contains substantive information rather than just a notice of report availability. The content fits best under Capital/Financing Update (CAP) as it relates to the company's financing activities and cash management updates.
2025-12-02 Chinese
关于公司股东阮鸿献先生部分股票质押融资提前还款解除质押的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the early repayment and release of stock pledge financing by a major shareholder, Mr. Ruan Hongxian, of Yixintang Pharmaceutical Group Co., Ltd. It details the number of shares involved, the pledge status, and risk warnings related to the pledged shares. The document is a formal disclosure of a shareholder's stock pledge financing and its changes, including risk disclosures and related filings. It does not contain financial statements, earnings data, or management discussion of financial results. It is not a report or presentation but a regulatory announcement about a shareholder's stock pledge financing activity. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership or related shareholder activities such as stock pledges by major shareholders.
2025-11-28 Chinese
关于公司股东阮鸿献先生进行股票质押登记的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding a shareholder's stock pledge registration. It details the pledge of shares by a major shareholder, including the number of shares pledged, the pledge period, and the risk warning related to the pledge. It also references related documents and confirms the authenticity of the disclosure. There is no financial report, earnings data, or management discussion. The content fits the category of a Major Shareholding Notification or related shareholder transaction disclosure. Given the focus on stock pledge by a significant shareholder, the most appropriate classification is Major Shareholding Notification (MRQ). The document length is short and it is a direct announcement, not a report or certification, so it is not RNS or RPA.
2025-11-26 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.